Depression Severe: Clinical Trials

12 trials for Depression Severe, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 2 unknown, 1 terminated. 4 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4Recruiting 2, Completed 1, Unknown 1
Phase 21Completed 1
Phase 31Terminated 1
Phase 41Completed 1

Follow Depression Severe: new trials by email Literature Review of Depression Severe trials Research Report on Depression Severe

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Kintsugi Voice Device Pivotal Study
Kintsugi Voice Device - Depression, Depression Moderate
CompletedKintsugi Mindful Wellness, Inc.16002025-03-272026-08-14
Kintsugi Voice Device Pilot Study
Kintsugi Voice Device - Depression, Depression Moderate
CompletedKintsugi Mindful Wellness, Inc.2622024-03-222026-08-14
Telehealth Behavioral Activation for Teens
Behavioral Activation - Depression, Suicide and Self-harm
Not applicableRecruitingBaylor College of Medicine2502024-03-012026-08-04
Integrated Depression Care
Integrated care - Depression Mild, Depression Moderate
Not applicableUnknownUniversity Ghent1502023-04-252024-06-06
Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
TNX-601 ER, Placebo - Depression, Depressive Disorder
Phase 2CompletedTonix Pharmaceuticals, Inc.1322023-03-022025-02-17
Exercise Recovery From Persistent Depression: A Thematic Analysis
Major Depressive Disorder, Depression Moderate
CompletedUniversity of Nottingham122022-12-012026-05-07
Brain Stimulation for Severe Depression
INTRACALVARIAL PREFRONTAL CORTICAL STIMULATION (IpCS) IN SEVERE TREATMENT-RESISTANT DEPRESSION - Depression Severe
Not applicableRecruitingInner Cosmos Inc202022-07-282026-04-15
The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis
OPUS YOUNG, Treatment as Usual - Schizophrenia, Schizotypal Disorder
Not applicableCompletedMental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital2842021-05-062026-08-20
Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression (OASIS-D)
Depression, Depression Moderate
UnknownCharite University, Berlin, Germany33312020-08-012024-02-07
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression
No Intervention - Depression, Clinical Depression
WithdrawnProgenaBiome2020-03-022025-06-05
Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department
Ketamine Hydrochloride, Normal saline - Suicide, Suicide Threat
Phase 3TerminatedNaval Medical Center Camp Lejeune12020-01-142025-05-14
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
Ketamine, Sodium Chloride 0.9% - Depression, Depression Severe
Phase 4CompletedMercyOne Des Moines Medical Center292019-10-182020-09-01

Narrower conditions

Depression (7)  ·  Depressive Disorder, Major (3)  ·  Suicide (3)  ·  Depressive Disorder (2)  ·  Self-Injurious Behavior (2)  ·  Suicidal Ideation (2)  ·  Anxiety Disorders (1)  ·  Depression, Postpartum (1)  ·  Emergencies (1)  ·  Mental Disorders (1)  ·  Motor Activity (1)  ·  Psychoses, Substance-Induced (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Schizophrenia, Paranoid (1)

Broader conditions

Behavior (9)  ·  Behavioral Symptoms (8)  ·  Mental Disorders (3)  ·  Mood Disorders (3)  ·  Self-Injurious Behavior (2)  ·  Chemically-Induced Disorders (1)  ·  Depressive Disorder (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Personality Disorders (1)  ·  Poisoning (1)  ·  Pregnancy Complications (1)  ·  Puerperal Disorders (1)

Interventions

Ketamine (2)  ·  Saline Solution (2)  ·  Delivery of Health Care, Integrated (1)  ·  Sodium Chloride (1)  ·  Therapeutics (1)  ·  tianeptine (1)

Sponsors

Kintsugi Mindful Wellness, Inc. (2)  ·  Baylor College of Medicine (1)  ·  Charite University, Berlin, Germany (1)  ·  Inner Cosmos Inc (1)  ·  Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (1)  ·  MercyOne Des Moines Medical Center (1)  ·  Naval Medical Center Camp Lejeune (1)  ·  ProgenaBiome (1)  ·  Tonix Pharmaceuticals, Inc. (1)  ·  University Ghent (1)  ·  University of Nottingham (1)

Countries

United States (8)  ·  Belgium (1)  ·  Denmark (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Adnan Iqbal, MD (1)  ·  Anne K Pagsberg, PhD (1)  ·  Christoph U Correll, MD (1)  ·  Eric Lenze, MD (1)  ·  Gregory Sullivan, MD (1)  ·  Kathryn Bress, PharmD (1)  ·  Liesbeth Borgermans, PhD (1)  ·  Lieven Annemans, PhD (1)  ·  Nathan H Butler, DO (1)  ·  Neil Nixon, BSc,MMedSci,MBBS,DM,FRCPsych (1)  ·  Sabine Hazan, MD (1)

Results publications

PMID 37828493, PMID 41347111, PMID 41654084